Observational studyRevista medica del Instituto Mexicano del Seguro Social2026
[Clinical and sociodemographic characterization of older adults with chronic diseases and advance directives].
Observational study in Revista medica del Instituto Mexicano del Seguro Social, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Population aging has increased the prevalence of older adults with advanced non-oncological chronic diseases, who face complex end-of-life decisions. Advance directives support autonomy; however, their implementation remains limited. Objective: To describe the clinical and sociodemographic characteristics of older adults with advanced non-oncological chronic diseases and with advance directives. Material and methods: Observational, descriptive, cross-sectional, retrospective study carried out in the Geriatrics Department of the Hospital General de México "Dr. Eduardo Liceaga." Records of patients ≥ 70 years in terminal or dying phases with signed advance directives (May 2023-June 2025) were reviewed; oncological disease was excluded. Descriptive and exploratory inferential analyses were performed using IBM SPSS, version 25.0. Results: Out of 124 records, 89 met criteria. Mean age was 81.6 years; females predominated. Advance directives were mainly formalized during hospitalization and advanced deterioration. Decisions were mostly made by family members, mainly adult children. Limitation of therapeutic effort and symptom control predominated, with no significant associations. Conclusions: Advance directives are established late, reflecting a reactive approach. Decision-making shows a homogeneous pattern toward comfort. Early implementation of advance directives should be promoted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.